Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1999

Primary Completion Date

March 31, 2003

Conditions
Ovarian Cancer
Interventions
DRUG

carboplatin

DRUG

cisplatin

DRUG

paclitaxel

DRUG

topotecan hydrochloride

Trial Locations (10)

10011

Saint Vincent Catholic Medical Center of New York, New York

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

10019

St. Luke's-Roosevelt Hospital Center - Roosevelt Division, New York

10021

New York Weill Cornell Cancer Center at Cornell University, New York

10029

Mount Sinai Medical Center, NY, New York

10032

Herbert Irving Comprehensive Cancer Center at Columbia University, New York

10461

Albert Einstein Clinical Cancer Center, The Bronx

10595

New York Medical College, Valhalla

11365

New York Hospital Medical Center of Queens, Fresh Meadows

53792-3236

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER

NCT00005051 - Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer | Biotech Hunter | Biotech Hunter